aHUS- some do some don’t
Article No. 321 20 February 2020 Recalling a couple of questions in the 2017 Rare Diseases Day video about something that…
Spotlight on Ravulizumab 4- side effects
Article No. 320 19 February 2020 Continuing in the series of news blogs about Ravulizumab, which so far has covered…
The study of genetics and aHUS
Article No. 319 14 February 2020 The study of genetics really began over 150 years ago when an Augustine Monk called…
aHUS trials watch 9
Article No. 318 13 February 2020 The alliance has reported on the development of OMS721 made by Omeros before. It is…
Spotlight on Ravulizumab 3- developments
Article No. 317 6 February 2020 Just a few days ago, Alexion reported on its financial performance for 2019. Its net…
aHUS or TMA syndromes consensus
Article No. 316 1 February 2020 The alliance has featured what are known as aHUS consensus or status publications about the…
Spotlight on Ravulizumab 2- use in specific populations
Article No. 315 30 January 2020 Following on from the first spotlight on ravulizumab article about its dosing (click here to…
aHUS- when PEX is a success
Article No. 314 28 January 2020 One of the interests of the aHUS patient community is whether remission from treatment can continue…
Undetermined Significance yet aHUS
Article No. 313 26 January 2020 During the alliance's series of articles late last year about the renaming of aHUS we…
- Go to the previous page
- 1
- …
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- …
- 83
- Go to the next page